NO148372B - PROCEDURE FOR THE PREPARATION OF BROOM HEXINE. - Google Patents

PROCEDURE FOR THE PREPARATION OF BROOM HEXINE.

Info

Publication number
NO148372B
NO148372B NO801617A NO801617A NO148372B NO 148372 B NO148372 B NO 148372B NO 801617 A NO801617 A NO 801617A NO 801617 A NO801617 A NO 801617A NO 148372 B NO148372 B NO 148372B
Authority
NO
Norway
Prior art keywords
reaction
procedure
bromhexine
dihydro
methylcyclohexylamine
Prior art date
Application number
NO801617A
Other languages
Norwegian (no)
Other versions
NO148372C (en
NO801617L (en
Inventor
Boerge Alhede
Niels Gelting
Herbert Preikschat
Original Assignee
Gea As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DK230179A external-priority patent/DK145718C/en
Priority claimed from DK230079A external-priority patent/DK145714C/en
Application filed by Gea As filed Critical Gea As
Publication of NO801617L publication Critical patent/NO801617L/en
Publication of NO148372B publication Critical patent/NO148372B/en
Publication of NO148372C publication Critical patent/NO148372C/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D265/00Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
    • C07D265/041,3-Oxazines; Hydrogenated 1,3-oxazines
    • C07D265/121,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems
    • C07D265/141,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring
    • C07D265/181,3-Oxazines; Hydrogenated 1,3-oxazines condensed with carbocyclic rings or ring systems condensed with one six-membered ring with hetero atoms directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Description

Foreliggende oppfinnelse vedrører en spesiell fremgangsmåte The present invention relates to a special method

til fremstilling av bromheksin, som er trivialbetegnelsen for N-(2-amino-3,5-dibrombenzyl)-N-metylcykloheksylamin, og som er et kjent stoff med slimløsende og hostestillende virkning. for the production of bromhexine, which is the trivial term for N-(2-amino-3,5-dibromobenzyl)-N-methylcyclohexylamine, and which is a known substance with expectorant and antitussive effects.

En rekke forskjellige fremgangsmåter til fremstilling av bromheksin er kjent og beskrevet i de danske patenter nr. 101.066, 101.301, 101.795 og 119.408, og i de danske fremlegnings-skrifter nr. 135.499, 135.574 og 135.680, samt i DE-OS 2.273.193. A number of different methods for the production of bromhexine are known and described in Danish patents no. 101,066, 101,301, 101,795 and 119,408, and in Danish patent documents no. 135,499, 135,574 and 135,680, as well as in DE-OS 2,273,193.

Disse kjente fremgangsmåter har hver for seg ulemper enten These known methods each have disadvantages either

i form av midlertidige beskyttelsesforanstaltninger for ikke-reagerende substituenter, eller i form av vanskelig tilgjengelig utgangsmaterialer eller av kostbare reduksjons-midlar, og felles for dem er at ulempene medfører reduserte utbytter. in the form of temporary protective measures for non-reacting substituents, or in the form of difficult-to-access starting materials or of expensive reducing agents, and common to them is that the disadvantages entail reduced yields.

Oppfinnelsens formål er å tilveiebringe en fremgangsmåte til fremstilling av bromheksin hvorved nevnte ulemper unngås og hvorved bromheksinet oppnås i høyt utbytte og i meget ren tilstand. The purpose of the invention is to provide a method for the production of bromhexine whereby the aforementioned disadvantages are avoided and whereby the bromhexine is obtained in high yield and in a very pure state.

Ifølge foreliggende oppfinnelse er det således tilveiebragt According to the present invention, it is thus provided

en fremgangsmåte for fremstilling av bromheksin med formelen: a process for the preparation of bromhexine with the formula:

og denne fremgangsmåte er kjennetegnet ved at 1,4-dihydro-2H-3,l-benzoksazin-2-on med formelen: and this method is characterized by the fact that 1,4-dihydro-2H-3,1-benzoxazin-2-one with the formula:

omsettes i iseddik eller annet egnet organisk oppløsnings-middel med fritt brom til 6,8-dibrom-l,4-dihydro-2H-3,1-benzoksazin-2-on, som deretter ved forhøyet temperatur og fortrinnsvis i nærvær av et inert oppløsningsmiddel omsettes med N-metylcykloheksylamin til bromheksin, som utvinnes av reaksjonsblandingen i form av et syreaddisjonssalt. reacted in glacial acetic acid or other suitable organic solvent with free bromine to 6,8-dibromo-1,4-dihydro-2H-3,1-benzoxazin-2-one, which then at elevated temperature and preferably in the presence of an inert solvent is reacted with N-methylcyclohexylamine to bromhexine, which is recovered from the reaction mixture in the form of an acid addition salt.

Omsetningene skjer ifølge nedenstående reaksjonsskjema. Turnovers take place according to the reaction chart below.

Utgangsstoffet I er et kjent stoff som kan fremstilles fra o-aminobenzylalkohol ved kondensasjon f.eks. med fosgen. The starting substance I is a known substance that can be prepared from o-aminobenzyl alcohol by condensation, e.g. with phosgene.

Mellomproduktet II er en ny dibromforbindelse som er tungt-oppløselig i vann og danner hvite krystaller som smelter ved 218-220°C (kfr. norsk patentsøknad 823977) . Intermediate II is a new dibromine compound that is poorly soluble in water and forms white crystals that melt at 218-220°C (cf. Norwegian patent application 823977).

Ved en foretrukken utførelsesform for foreliggende fremgangsmåte foretas omsetningen med N-metylcykloheksylamin i opp-løsning i N-monometylformamid, idet det således oppnås et utbytte på opptil 90% ved omsetningen. In a preferred embodiment of the present method, the reaction is carried out with N-methylcyclohexylamine in solution in N-monomethylformamide, thus achieving a yield of up to 90% in the reaction.

Når det gjelder bromeringsreaksjonen i foreliggende frem-gangsmåtes første trinn, så representerer den ikke en helt vanlig aromatisk bromeringsreaksjon idet man meget vel kunne tenke seg at de to bromatomer som innføres angripes av det reaktive hydrogenatom ved nitrogenatomet i det sekundære amin, som anvendes som reaktant. As regards the bromination reaction in the first step of the present method, it does not represent a completely normal aromatic bromination reaction, since one could very well imagine that the two bromine atoms that are introduced are attacked by the reactive hydrogen atom at the nitrogen atom in the secondary amine, which is used as reactant .

Fremgangsmåtens annet trinn og det uventede som her skjer, skal i det følgende belyses under henvisning til litteraturen. Som eksempel kan nevnes at J.F. Brunet og M. Benton Naff, kfr. J.Am.Chem.Soc. 88, side 4001 (1966) inngående be-handler omsetningen av isatoinsyreanhydrid med aminer som fører til to forskjellige produkter The second step of the procedure and the unexpected that occurs here will be explained below with reference to the literature. As an example, it can be mentioned that J.F. Brunet and M. Benton Naff, see J.Am.Chem.Soc. 88, page 4001 (1966) discusses in detail the reaction of isatoic anhydride with amines leading to two different products

Betrakter man nå det andre trinn i foreliggende fremgangsmåte, er det klart at man a priori måtte forvente flere mulige reaksjonsprodukter, nemlig If one now considers the second step in the present method, it is clear that a priori one would have to expect several possible reaction products, viz

Forbindelsen med formel A kan betraktes som en cyklisk uretan-forbindelse, idet den inneholder grupperingen -Ct^-O-CO-NH-,. og man skulle derfor ifølge litteraturen forvente reaksjonen A —> B'. Således angis i E.H. Rodd Chemistry of Carbon Compounds, IB, 901 (1953), at uretanene er stabile, flyktige krystallinske forbindelser som er lett oppløselige i vann, alkohol og eter. Mange av deres kjemiske egenskaper ville være forventet utfra deres gitte strukturer. Således er-stattes alkoksygruppen ved oppvarming med ammoniakk, hvilket gir urea. Ved analogikonklusjon kan det derfor sies at substituerte ureaforbindelser oppnås med aminer. The compound of formula A can be considered a cyclic urethane compound, in that it contains the grouping -Ct^-O-CO-NH-,. and one should therefore, according to the literature, expect the reaction A —> B'. Thus stated in E.H. Rodd Chemistry of Carbon Compounds, IB, 901 (1953), that the urethanes are stable, volatile crystalline compounds which are readily soluble in water, alcohol and ether. Many of their chemical properties would be expected from their given structures. Thus, the alkoxy group is replaced by heating with ammonia, which gives urea. By analogy, it can therefore be said that substituted urea compounds are obtained with amines.

I D.H.R. Barton og W.D. Ollis "Comprehensive Organic Chemistry", 2, 1084 (1979) beskrives uretaners, betegnet karbamater, kjemi. Det,angis her at den mest karakteristiske reaksjon for karbamater er med nukleofile materialer, og at den totale reaksjon (kfr. skjema 7) er erstatning av alkoksy-eller aryloksygruppen med f.eks. aminer (for dannelse av ureaforbindelser) eller alkoholer (transforestring). In D.H.R. Barton and W.D. Ollis "Comprehensive Organic Chemistry", 2, 1084 (1979) describes the chemistry of urethanes, termed carbamates. It is stated here that the most characteristic reaction for carbamates is with nucleophilic materials, and that the overall reaction (cf. scheme 7) is replacement of the alkoxy or aryloxy group with e.g. amines (for the formation of urea compounds) or alcohols (transesterification).

Forskjellige litteratursteder angir også at reaksjonen Various literature sources also state that the reaction

A —5> B" kunne forventes og at det derfor må anses som sær-egent og overraskende at man får forbindelsen B som hoved-produkt i høyt utbytte i foreliggende oppfinnelse. A —5> B" could be expected and that it must therefore be considered peculiar and surprising that compound B is obtained as the main product in high yield in the present invention.

Betraktninger med bakgrunn i de monocykliske analoge systemer Considerations with a background in the monocyclic analogue systems

har ikke kunnet foretas fordi disses kjemi ikke er ut-forsket. Derimot har den tilsvarende dihydroform: have not been able to be carried out because their chemistry has not been investigated. In contrast, it has the corresponding dihydro form:

vært gjenstand for kjemisk interesse. Omsetning av N-usubstituerte 1,3-oksazin-2-oner med aminer føres som regel til dannelse av tetrahydro-2-pyrimidoner, mens forbindelser med elektrondonerende substituenter på oksazinringens nitrogenatom har tendens til å gi trimetylendiaminderivater, kfr. CA. 83, 77996 a (1975) og CA. 86, 29126 g (1977), samt svensk utlegningsskrift nr. 322.529. been the subject of chemical interest. Reaction of N-unsubstituted 1,3-oxazin-2-ones with amines usually leads to the formation of tetrahydro-2-pyrimidones, while compounds with electron-donating substituents on the nitrogen atom of the oxazine ring tend to give trimethylenediamine derivatives, cf. CA. 83, 77996a (1975) and CA. 86, 29126 g (1977), as well as Swedish interpretation document no. 322,529.

Foreliggende fremgangsmåte belyses ved følgende utførelses-eksempler. The present method is illustrated by the following design examples.

Eksempel 1 Example 1

Til en oppløsning av 9,0 g (0,0604 mol) 1,4-dihydro-2H-3,1-benzoksazin-2-on i 40 ml iseddik ble det tilsatt 60,9 g To a solution of 9.0 g (0.0604 mol) 1,4-dihydro-2H-3,1-benzoxazin-2-one in 40 ml of glacial acetic acid was added 60.9 g

(0,38 mol) brom, hvorved temperaturen steg fra 24° til 74°C. Reaksjonsblandingen ble hensatt til den var avkjølt til rom-temperatur og ble deretter helt i 500 ml vann hvorved man fikk en utfelling av den bromerte benzoksazinon. Denne for-bindelse ble frafiltrert og vasket på filteret først med vann, deretter med en fortynnet oppløsning av natriumhydro-gensulfitt og tilslutt med heksan. (0.38 mol) of bromine, whereby the temperature rose from 24° to 74°C. The reaction mixture was left until it had cooled to room temperature and was then poured into 500 ml of water whereby a precipitate of the brominated benzoxazinone was obtained. This compound was filtered off and washed on the filter first with water, then with a dilute solution of sodium hydrogen sulphite and finally with hexane.

Fra modervæsken og vaskevann kunne overskudd av brom gjen-vinnes ved destillasjon. Excess bromine could be recovered from the mother liquor and wash water by distillation.

Utbyttet av den bromerte benzoksazinon var 16,5 g (0,0537 The yield of the brominated benzoxazinone was 16.5 g (0.0537

mol) tilsvarende 89% av det teoretiske utbytte. Smeltepunktet var 218-220°C og tynnsjiktskromatografi viste ingen urenheter. mol) corresponding to 89% of the theoretical yield. The melting point was 218-220°C and thin layer chromatography showed no impurities.

En blanding av 3,07 g (0,010 mol) av den oppnådde 6,8-dibrom-1,4-dihydro-2H-3,l-benzoksazin-2-on og 4,52 g (0,040 mol) N-metylcykloheksylamin i 10 ml N-monometylformamid, ble oppvarmet under omrøring og tilbakeløp i 2 timer på et 210°C varmt oljebad. Etter avkjøling ble reaksjonsblandingen helt i 70 ml vann og det ble tilsatt konsentrert saltsyre til sur reaksjon. A mixture of 3.07 g (0.010 mol) of the obtained 6,8-dibromo-1,4-dihydro-2H-3,1-benzoxazin-2-one and 4.52 g (0.040 mol) of N-methylcyclohexylamine in 10 ml of N-monomethylformamide, was heated with stirring and reflux for 2 hours in a 210°C hot oil bath. After cooling, the reaction mixture was poured into 70 ml of water and concentrated hydrochloric acid was added for an acidic reaction.

Ved avkjøling i isvann under omrøring fikk man utkrystalli-sert N-(2-amino-3,5-dibrombenzyl)-N-metyl-cykloheksylammonium-klorid (bromheksin, hydroklorid)', som etter 1 times forløp ble frafiltrert, vasket med vann og tørket. Utbyttet var 3,7 g (8,97 mmol), som tilsvarer 89,7% av det teoretiske. Smeltepunktet var 232-233,5°C og stoffet var analytisk rent. By cooling in ice water with stirring, N-(2-amino-3,5-dibromobenzyl)-N-methyl-cyclohexylammonium chloride (bromohexine, hydrochloride) crystallized out, which after 1 hour was filtered off, washed with water and dried. The yield was 3.7 g (8.97 mmol), which corresponds to 89.7% of the theoretical. The melting point was 232-233.5°C and the substance was analytically pure.

Eksempel 2 Example 2

En blanding av 1,65 g (5,4 mmol) av det ifølge eksempel 1 oppnådde 6,8-dibrom-l,4-dihydro-2H-3,l-benzoksazin-2-on og 2,4 g (21 mmol) N-metylcykloheksylamin i 10 ml dietylen-glykol, ble oppvarmet under omrøring og tilbakeløp i 20 timer på et 210°C varmt oljebad. Etter avkjøling ble 150 ml vann og konsentrert saltsyre tilsatt til sur reaksjon, hvoretter blandingen ble oppvarmet til tilbakeløpstemperatur. Til den kokende blanding ble det tilsatt 10 ml etanol og aktivt karbon, hvoretter det ble foretatt klarfiltrering ved til-bakeløpstemperaturen. A mixture of 1.65 g (5.4 mmol) of the 6,8-dibromo-1,4-dihydro-2H-3,1-benzoxazin-2-one obtained according to example 1 and 2.4 g (21 mmol ) N-methylcyclohexylamine in 10 ml of diethylene glycol, was heated with stirring and reflux for 20 hours in a 210°C hot oil bath. After cooling, 150 ml of water and concentrated hydrochloric acid were added to acid reaction, after which the mixture was heated to reflux temperature. 10 ml of ethanol and activated carbon were added to the boiling mixture, after which clear filtration was carried out at the reflux temperature.

Filtratet ble avkjølt i isvann, hvorved N-(2-amino-3,5-di-brombenzyl) -N-metylcykloheksylammoniumklorid ble utkrystal-lisert. Stoffet ble frafiltrert og vasket med vann. Utbyttet av det analytiske rene stoff var 1,1 g (2,67 mmol), tilsvarende 49,4% av det teoretiske. The filtrate was cooled in ice water, whereby N-(2-amino-3,5-dibromobenzyl)-N-methylcyclohexylammonium chloride was crystallized out. The substance was filtered off and washed with water. The yield of the analytically pure substance was 1.1 g (2.67 mmol), corresponding to 49.4% of the theoretical.

Claims (2)

1. Fremgangsmåte for fremstilling av bromheksin med formelen: karakterisert ved at 1,4-dihydro-2H-3,1-benzoksazin-2-on med formelen: omsettes i iseddik eller annet egnet organisk oppløsnings-middel med fritt brom til 6,8-dibrom-l,4-dihydro-2H-3,1-benzoksazin-2-on, som deretter ved forhøyet temperatur og fortrinnsvis i nærvær av et inert oppløsningsmiddel omsettes med N-metylcykloheksylamin til bromheksin, som utvinnes av reaksjonsblandingen i form av et syreaddisjonssalt.1. Procedure for the production of bromhexine with the formula: characterized in that 1,4-dihydro-2H-3,1-benzoxazin-2-one with the formula: reacted in glacial acetic acid or other suitable organic solvent with free bromine to 6,8-dibromo-1,4-dihydro-2H-3,1-benzoxazin-2-one, which then at elevated temperature and preferably in the presence of an inert solvent is reacted with N-methylcyclohexylamine to bromhexine, which is recovered from the reaction mixture in the form of an acid addition salt. 2. Fremgangsmåte ifølge krav 1, karakterisert ved at omsetningen med N-metylcykloheksylamin foretas i N-monometylformamid.2. Process according to claim 1, characterized in that the reaction with N-methylcyclohexylamine is carried out in N-monomethylformamide.
NO801617A 1979-06-01 1980-05-30 PROCEDURE FOR THE PREPARATION OF BROOM HEXINE NO148372C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK230179A DK145718C (en) 1979-06-01 1979-06-01 DIBROME COMPOUND USE AS INTERMEDIATE IN THE PREPARATION OF N- (2-AMINO-3,5-DIBROMBENZYL) -N-METYLCYCLOHEXYLAMINE
DK230079A DK145714C (en) 1979-06-01 1979-06-01 METHOD FOR PREPARING N- (2-AMINO-3,5-DIBROMBENZYL) -N-METYLYCYLOHEXYLAMINE

Publications (3)

Publication Number Publication Date
NO801617L NO801617L (en) 1980-12-02
NO148372B true NO148372B (en) 1983-06-20
NO148372C NO148372C (en) 1983-09-28

Family

ID=26066477

Family Applications (2)

Application Number Title Priority Date Filing Date
NO801617A NO148372C (en) 1979-06-01 1980-05-30 PROCEDURE FOR THE PREPARATION OF BROOM HEXINE
NO823977A NO148415C (en) 1979-06-01 1982-11-26 INTERMEDIATE FOR USE IN PREPARATION OF N- (2-AMINO-3,5-DIBROMBENZYL) -N-METHYLYCYLOHEXYLAMINE

Family Applications After (1)

Application Number Title Priority Date Filing Date
NO823977A NO148415C (en) 1979-06-01 1982-11-26 INTERMEDIATE FOR USE IN PREPARATION OF N- (2-AMINO-3,5-DIBROMBENZYL) -N-METHYLYCYLOHEXYLAMINE

Country Status (11)

Country Link
AT (1) AT371800B (en)
CH (1) CH642617A5 (en)
DE (1) DE3020604A1 (en)
ES (1) ES492005A0 (en)
FI (1) FI68808C (en)
GB (1) GB2053900B (en)
IE (1) IE49820B1 (en)
KE (1) KE3302A (en)
NL (1) NL8003153A (en)
NO (2) NO148372C (en)
SE (1) SE433847B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2881955B1 (en) 2005-02-11 2007-05-11 Oreal COSMETIC NANOEMULSION CONTAINING HYDROXYL UREA COMPOUND
CN102775316B (en) * 2012-08-17 2013-06-12 夏智红 Bromhexine hydrochloride compound and medicine composition thereof
CN102924295B (en) * 2012-10-09 2014-10-29 石家庄东方药业有限公司 Bromhexine hydrochloride crystal as well as preparation method and application of crystal
CN103145564B (en) * 2013-03-15 2014-06-18 湖北美林药业有限公司 Bromhexine hydrochloride compound and pharmaceutical composition thereof

Also Published As

Publication number Publication date
GB2053900B (en) 1983-04-20
IE801081L (en) 1980-12-01
NL8003153A (en) 1980-12-03
FI68808B (en) 1985-07-31
NO148372C (en) 1983-09-28
SE433847B (en) 1984-06-18
NO823977L (en) 1980-12-02
ATA288580A (en) 1982-12-15
GB2053900A (en) 1981-02-11
DE3020604A1 (en) 1980-12-11
FI68808C (en) 1985-11-11
ES8104185A1 (en) 1981-04-01
NO148415B (en) 1983-06-27
FI801705A (en) 1980-12-02
SE8003874L (en) 1980-12-02
CH642617A5 (en) 1984-04-30
ES492005A0 (en) 1981-04-01
NO801617L (en) 1980-12-02
AT371800B (en) 1983-07-25
KE3302A (en) 1983-08-19
IE49820B1 (en) 1985-12-25
NO148415C (en) 1983-10-12

Similar Documents

Publication Publication Date Title
HU187562B (en) Process for the preparation of 3,4-dihydro-2-bracket-1h-bracket closed-imino-quinazolin-3-acetic acid derivatives
US20040242875A1 (en) Novel processes
CN112707836B (en) Preparation method of m-diamide compound
EP1373268B1 (en) Method for the manufacture of anagrelide
US9981917B2 (en) Preparation method for revaprazan hydrochloride
WO2020019529A1 (en) Preparation method for 4-(4-aminophenyl)morpholin-3-one
NO148372B (en) PROCEDURE FOR THE PREPARATION OF BROOM HEXINE.
NO135285B (en)
KR20140013232A (en) Process for the preparation of n-(2-hydroxyethyl)nicotinamide and nicorandil
JP2001322979A (en) Method for producing 3-bromoquinoline
JP6276894B2 (en) Method for preparing quinazoline derivative
CN110218189B (en) Abelide intermediate and simple preparation method of Abelide
EP3356372B1 (en) Novel process for preparing thienopyrimidine compound and intermediates used therein
JPH0477477A (en) Production of thiadiazoleacetic acid derivative
NO152298B (en) PROCESS FOR PREPARING 6,7-DIMETOXY-4-AMINO-2- (4- (FUROYL) -1-PIPERAZINYL) -KINAZOLINE HYDROCHLORIDE
US4146713A (en) Method of preparing 3-morpholino-2-cyanoacrylamide
SU999967A3 (en) Process for producing 6-n-substituted 6-amino-3-pyridazinyl hydrizines or their salts
JPH04169583A (en) Phenothiazine derivative and its production
DK145714B (en) Process for preparing N-(2-amino-3,5-dibromobenzyl)-N- methylcyclohexylamine
EP1492791B1 (en) Crystal and solvate of 2-amino-6-benzyloxypurine and production methods thereof
US2784188A (en) Synthesis of 4, 5-diamino-6-dimethylamino pyrimidine
US5066806A (en) Novel separation process
WO2011124638A1 (en) Pimobendan manufacturing process
CN117466762A (en) Preparation method of 2-amino-3, 5-dichloro-N-methylbenzamide
KR810000423B1 (en) Process for the preparation of n-alkyldiphenyl amines